en
E-mail us

The Bioprocessing Summit 2024 - Meet Crystal Bio at Booth T13

Join Crystal Bio's Co-founder, CTO, and Head of USA BD Ye Gu,  Ph.D., as she presents at the Immuno-Oncology Summit 2024.


Title: Analytical Methods to Assess Critical Quality Attribute in mRNA-LNP Modality

Phase-appropriate strategies are pivotal to ensure the analyses to be adequate at each stage. Employing advanced analytical techniques such as high-resolution mass spectrometry, properly and timely, can address potential CMC issues to mitigate risks of delaying progress. This presentation will discuss the application of phase-appropriate strategies for analyses needed at each stage, and related examples such as developability and serum stability studies will be illustrated to highlight the application. 


Date: August 19-22, 2024

Location: Sheraton Boston (39 Dalton Street)

Booth: T13


Related CRO & CDMO Services

Contact Us
bd_global@crystalpharmatech.com +1-609-604-8303
U.S
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China, 215123
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
bd_global@crystalpharmatech.com +1-609-604-8303